Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Other Non-Current Liabilities: 2021-2024

Historic Other Non-Current Liabilities for Core Scientific (CORZ) over the last 4 years, with Dec 2024 value amounting to $1.1 billion.

  • Core Scientific's Other Non-Current Liabilities rose 30.79% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 30.79%. This contributed to the annual value of $1.1 billion for FY2024, which is 1004.63% up from last year.
  • Latest data reveals that Core Scientific reported Other Non-Current Liabilities of $1.1 billion as of FY2024, which was up 1,004.63% from $99.3 million recorded in FY2023.
  • In the past 5 years, Core Scientific's Other Non-Current Liabilities registered a high of $1.1 billion during FY2024, and its lowest value of $18.5 million during FY2021.
  • Its 3-year average for Other Non-Current Liabilities is $741.3 million, with a median of $1.0 billion in 2022.
  • Per our database at Business Quant, Core Scientific's Other Non-Current Liabilities soared by 5,443.75% in 2022 and then plummeted by 90.33% in 2023.
  • Core Scientific's Other Non-Current Liabilities (Yearly) stood at $18.5 million in 2021, then skyrocketed by 5,443.75% to $1.0 billion in 2022, then crashed by 90.33% to $99.3 million in 2023, then surged by 1,004.63% to $1.1 billion in 2024.